Natriuretic peptide system in fetal heart and circulation

Journal of Hypertension

Volumn 20, Issue 5, 2002, Pages 785-791

  Walther, Thomas ^a   Schultheiss, Heinz Peter ^a   Tschöpe, Carsten ^a   Stepan, Holger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Embryology; Gene expression; Natriuretic peptide; Review

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C;

CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIURESIS; EMBRYO; EMBRYO DEVELOPMENT; FETUS; FETUS CIRCULATION; FETUS DEVELOPMENT; FETUS HEART; HOMEOSTASIS; HUMAN; NATRIURESIS; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0036562925     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200205000-00001     Document Type: Review

References (67)

1. Regulation of gene expression in the endocrine heart
2. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis
3. Developmental changes in the rat atriopeptin hormonal system
4. Atrial natriuretic peptide in heart and specific binding in organs from fetal and newborn rats
5. Gene expression of atrial natriuretic factor in ovine fetal heart during development
6. Developmental changes in atrial natriuretic factor content and localization of its messenger ribonucleic acid in ovine fetal heart
7. Specific heart granules and natriuretic peptide in the developing myocardium of fetal and neonatal rats and hamsters
8. Atrial natriuretic factor in the heart of the human embryo
9. Expression of the atrial natriuretic peptide gene in human fetal heart
10. Atrial natriuretic peptide distribution in fetal and failed adult human hearts
11. Ultrastructural immunolocalization of the atrial natriuretic factor pathways in fetal, neonatal, and adult Syrian hamsters: From the atrial cardiomyocytes to the circulation via the endocardium, atrial capillaries and epicardium
12. Altered regulation of natriuretic peptides in the rat heart by prenatal exposure to morphine
13. Identification of a biologically active circulating form of rat atrial natriuretic factor
14. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man
15. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma
16. Physiological role of silent receptors of atrial natriuretic factor
17. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11
18. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction
19. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
20. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor
21. The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man
22. Plasma atrial natriuretic peptide response to volume expansion in the ovine fetus
23. Hemodynamic and hormonal responses to atrial distension in the ovine fetus
24. Amino-terminal proBNP in ovine plasma: Evidence for enhanced secretion in response to cardiac overload
25. Plasma atrial natriuretic peptide in human fetus: Response to intravascular blood transfusion
26. Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization
27. Prediction of fetal anemia by measurement of mean blood flow velocity in the fetal aorta
28. Dual natriuretic peptide response to volume load in fetal circulation
29. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction
30. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure
31. Dual natriuretic peptide system in experimental heart failure
32. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern
33. Regulation of atrial natriuretic factor release by endothelin in ovine fetuses
34. Fetal hypoxia elevates plasma atrial natriuretic factor concentration
35. Effects of phenylephrine induced increase in arterial pressure and closure of the ductus arteriosus on the secretion of atrial natriuretic peptide (ANP) and renin in the ovine fetus
36. Increased natriuretic peptides in fetal hearts of diabetic rats
37. Development of immunoreactive atrial natriuretic peptide in fetal hearts of spontaneously hypertensive and Wistar-Kyoto rats
38. Is human atrial natriuretic peptide in fetal blood useful as a parameter to detect the decompensate state of the fetal heart?
39. Umbilical venous guanosine 3′,5′-cyclic phosphate (cGMP) concentration increases in asphyxiated newborns
40. Alpha-atrial natriuretic peptide-induced attenuation of vasoconstriction in the fetal circulation of the human isolated perfused placenta
41. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses
42. Pulmonary vascular effects of exogenous atrial natriuretic peptide in sheep fetuses
43. Cardiovascular and fluid responses to atrial natriuretic factor in sheep fetus
44. Fetal cardiovascular, endocrine, and fluid responses to atrial natriuretic factor infusion
45. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: Temporal changes in embryos and placenta
46. Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice
47. Expression of natriuretic peptide system during embryonic stem cell vasculogenesis
48. Detection of C-type natriuretic peptide in fetal circulation
49. Atrial natriuretic peptide receptors in normal human placentas
50. Ontogeny of fetal renal atrium natriuretic factor receptors
51. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells
52. ANF system in the newborn piglet pulmonary vessels
53. Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions
54. Endocardial localization and characterization of natriuretic peptide binding sites in human fetal and adult heart
55. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
56. Cardiac fibrosis in mice lacking brain natriuretic peptide
57. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide
58. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
59. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice
60. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes
61. Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: Role of cardiovascular sympathetic tone
62. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene
63. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide
64. Dwarfism and early death in mice lacking C-type natriuretic peptide
65. Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways
66. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
67. Absence of transplacental transfer of atrial natriuretic peptide in the rat: Direct experimental evidence